Display options
Cite
Zhai W, Feng R, Wang H, et al. Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour Biol. 2015;36(5):3179-89doi: 10.1007/s13277-015-3384-4.
Zhai, W., Feng, R., Wang, H., & Wang, Y. (2015). Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 36(5), 3179-89. https://doi.org/10.1007/s13277-015-3384-4
Zhai, Wenlong, et al. "Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis." Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 36,5 (2015): 3179-89. doi: https://doi.org/10.1007/s13277-015-3384-4
Zhai W, Feng R, Wang H, Wang Y. Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour Biol. 2015 May;36(5):3179-89. doi: 10.1007/s13277-015-3384-4. Epub 2015 Apr 03. PMID: 25835974.
Copy Download .nbib Format: NLM
Share it on

Tumour Biol. 2015 May;36(5):3179-89. doi: 10.1007/s13277-015-3384-4. Epub 2015 Apr 03.

Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Wenlong Zhai, Ruo Feng, Haiyu Wang, Yadong Wang

Affiliations

  1. Department of General Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

PMID: 25835974 DOI: 10.1007/s13277-015-3384-4

Abstract

We read with great interest the paper titled "X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis" published by Wang et al in Tumor Biology, 2014, 35:411-418. Their results suggest that codon 399 polymorphism of XRCC1 gene might contribute to individual's susceptibility to lung cancer in Asian population and especially in nonsmoking Chinese women. The result is encouraging. Nevertheless, several key issues are worth noticing.

References

  1. Lung Cancer. 2007 May;56(2):153-60 - PubMed
  2. Carcinogenesis. 2009 Jan;30(1):78-87 - PubMed
  3. Asian Pac J Cancer Prev. 2010;11(5):1181-6 - PubMed
  4. EMBO J. 2001 Nov 15;20(22):6530-9 - PubMed
  5. Anticancer Res. 2005 Jan-Feb;25(1B):537-42 - PubMed
  6. Biochem Genet. 2004 Dec;42(11-12):453-60 - PubMed
  7. J Thorac Oncol. 2010 Dec;5(12):1912-21 - PubMed
  8. Lung Cancer. 2009 Sep;65(3):268-73 - PubMed
  9. Asian Pac J Cancer Prev. 2013;14(9):5275-9 - PubMed
  10. Biometrics. 1994 Dec;50(4):1088-101 - PubMed
  11. Tumour Biol. 2015 May;36(5):3745-50 - PubMed
  12. Int J Mol Med. 2005 Oct;16(4):709-16 - PubMed
  13. Mutat Res. 2011 May 10;709-710:21-31 - PubMed
  14. J Thorac Oncol. 2012 Jun;7(6):954-62 - PubMed
  15. PLoS One. 2013;8(2):e56213 - PubMed
  16. BMC Cancer. 2007 Aug 16;7:162 - PubMed
  17. Control Clin Trials. 1986 Sep;7(3):177-88 - PubMed
  18. Cancer Genet. 2015 Jan-Feb;208(1-2):19-24 - PubMed
  19. Cancer Lett. 2003 Mar 10;191(2):171-8 - PubMed
  20. Carcinogenesis. 2006 May;27(5):997-1007 - PubMed
  21. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3081-9 - PubMed
  22. Lung Cancer. 2011 Aug;73(2):138-46 - PubMed
  23. Carcinogenesis. 2002 Aug;23(8):1321-5 - PubMed
  24. Mutat Res. 2007 Jul 28;631(2):101-10 - PubMed
  25. Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):119-23 - PubMed
  26. Anticancer Res. 2008 Sep-Oct;28(5B):2941-6 - PubMed
  27. Mutat Res. 2001 Jan 5;461(4):273-8 - PubMed
  28. Cancer Res. 1998 Feb 15;58(4):604-8 - PubMed
  29. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65 - PubMed
  30. Lung Cancer. 2001 Dec;34(3):333-9 - PubMed
  31. Carcinogenesis. 2004 Aug;25(8):1395-401 - PubMed
  32. Environ Mol Mutagen. 2004;44(1):74-82 - PubMed
  33. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):23-7 - PubMed
  34. Arch Med Res. 2011 Apr;42(3):226-34 - PubMed
  35. Clin Respir J. 2016 May;10 (3):311-7 - PubMed
  36. Cancer. 2004 Dec 15;101(12):2802-8 - PubMed
  37. Oncogene. 2006 Jun 15;25(25):3613-20 - PubMed
  38. Carcinogenesis. 2006 Mar;27(3):560-7 - PubMed
  39. Mol Biol Rep. 2013 Sep;40(9):5261-73 - PubMed
  40. Tumour Biol. 2014 Jun;35(6):5629-35 - PubMed
  41. Carcinogenesis. 2009 Apr;30(4):626-35 - PubMed
  42. Tumour Biol. 2013 Oct;34(5):2989-94 - PubMed
  43. Cancer Genet Cytogenet. 2005 Oct 1;162(1):10-20 - PubMed
  44. Lung Cancer. 2008 Nov;62(2):145-51 - PubMed
  45. Wei Sheng Yan Jiu. 2012 Mar;41(2):251-6 - PubMed
  46. Asian Pac J Cancer Prev. 2014;15(5):1993-9 - PubMed
  47. BMJ. 1997 Sep 13;315(7109):629-34 - PubMed
  48. Pharmacogenet Genomics. 2005 Jul;15(7):457-63 - PubMed
  49. Carcinogenesis. 2004 Dec;25(12):2433-41 - PubMed
  50. Cancer Genet Cytogenet. 2009 Jan 1;188(1):26-31 - PubMed
  51. Tumour Biol. 2013 Oct;34(5):2843-8 - PubMed
  52. J Clin Diagn Res. 2014 Nov;8(11):CC17-20 - PubMed
  53. Tumour Biol. 2014 Jan;35(1):411-8 - PubMed
  54. DNA Cell Biol. 2007 Mar;26(3):186-91 - PubMed
  55. Zhongguo Fei Ai Za Zhi. 2005 Oct 20;8(5):431-4 - PubMed
  56. Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):713-6 - PubMed
  57. J Natl Cancer Inst. 2005 Apr 20;97(8):567-76 - PubMed
  58. Cancer Res. 2005 Feb 1;65(3):722-6 - PubMed

Substances

MeSH terms

Publication Types